Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: A review and summary of the literature

Diagnostic Cytopathology

Volumn 40, Issue 6, 2012, Pages 491-497

  Jarboe, Elke A ^a,b   Hunt, Jason P ^a   Layfield, Lester J ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

cytology; fine needle aspiration; HPV; oropharynx

Indexed keywords

PROTEIN P16;

ASPIRATION BIOPSY; ASSAY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SCREENING; CELL STRUCTURE; CONFERENCE PAPER; DIAGNOSTIC TEST; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; NONHUMAN; NUCLEIC ACID HYBRIDIZATION; OROPHARYNX CARCINOMA; OROPHARYNX SQUAMOUS CELL CARCINOMA; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; CYTODIAGNOSIS; DNA, VIRAL; EARLY DETECTION OF CANCER; HUMANS; LYMPH NODES; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS;

EID: 84861572114     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22837     Document Type: Conference Paper

References (64)

1. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-3287.
2. Elwood JM, Pearson JC, Skippen DH, Jackson SM,. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer 1984; 34: 603-612.
3. Brugere J, Guenel P, Leclerc A, Rodriguez J,. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986; 57: 391-395.
4. Tuyns AJ, Estève J, Raymond L, et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 1988; 41: 483-491.
5. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
6. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: An emerging epidemic of human papillomavirus-associated cancers? Cancer 2007; 110: 1429-1435.
7. Ernster JA, Sciotto CG, O'Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 2007; 117: 2115-2128.
8. Westra WH,. The changing face of head and neck cancer in the 21st century: The impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009; 3: 78-81.
9. Gillison ML,. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 744-754.
10. Smith EM, Ritchie JM, Summersgill KF, et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 2004; 108: 766-772.
11. Fakhry C, Gillison ML,. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006; 24: 2606-2611.
12. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E,. Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survival. Int J Cancer 2000; 89: 300-304.
13. Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM,. Human papillomavirus positive squamous cell carcinoma of the oropharynx: A radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92: 805-813.
14. Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009; 140: 228-234.
15. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
16. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
17. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
18. Bishop JA, Maleki Z, Valsamakis A, et al. Application of the Hybrid Capture 2 assay to squamous cell carcinomas of the head and neck: A convenient liquid-phase approach for the reliable determination of human papillomavirus status. Cancer Cytopathol, 2011 July 12 [Epub ahead of print].
19. Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH,. Detection of human papillomavirus in cervical lymph nodes: A highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003; 9: 6469-6475.
20. Begum S, Gillison ML, Nicol TL, Westra WH,. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2007; 13: 1186-1191.
21. Agrawal Y, Koch WM, Xiao W, et al. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res 2008; 14: 7143-7150.
22. Chuang AY, Chuang TC, Chang S, et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008; 44: 915-919.
23. Zhao M, Rosenbaum E, Carvalho AL, et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005; 117: 605-610.
24. Steel BL, Schwartz MR, Ramzy I,. Fine needle aspiration biopsy in the diagnosis of lymphadenopathy in 1,103 patients. Role, limitations and analysis of diagnostic pitfalls. Acta Cytol 1995; 39: 76-81.
25. Betsill WL, Jr, Hajdu SI,. Percutaneous aspiration biopsy of lymph nodes. Am J Clin Pathol 1980; 73: 471-479.
26. Frable WJ,. Thin-needle aspiration biopsy. A personal experience with 469 cases. Am J Clin Pathol 1976; 65: 168-182.
27. Mehrotra R, Sharma N, Umudum H, Ceyhan K, Rezanko T,. The role of cytopathology in diagnosing HPV induced oropharyngeal lesions. Diagn Cytopathol, 2011 Jun 22 [Epub ahead of print].
28. Benevolo M, Mottolese M, Marandino F, et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions. Mod Pathol 2006; 19: 384-391.
29. Mendelsohn AH, Lai CK, Shintaku IP, et al. Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010; 120: 1788-1794.
30. Lewis JS, Jr, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: An entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 2010; 34: 1088-1096.
31. Cunningham LL, Jr, Pagano GM, Li M, et al. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 77-81.
32. Anderson KS, Wong J, D'Souza G, et al. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer 2011; 104: 1896-1905.
33. Zhang MQ, El-Mofty SK, Dávila RM,. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: A tool for identifying the site of an occult head and neck primary. Cancer 2008; 114: 118-123.
34. Cantley RL, Gabrielli E, Montebelli F, Cimbaluk D, Gattuso P, Petruzzelli G,. Ancillary studies in determining human papillomavirus status of squamous cell carcinoma of the oropharynx: A review. Patholog Res Int, in press.
35. Acay R, Rezende N, Fontes A, Aburad A, Nunes F, Sousa S,. Human papillomavirus as a risk factor in oral carcinogenesis: A study using in situ hybridization with signal amplification. Oral Microbiol Immunol 2008; 23: 271-274.
36. Chuang AY, Chuang TC, Chang S, et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. Oral Oncol 2008; 44: 915-919.
37. Jarboe EA, Willis M, Bentz B, et al. Detection of human papillomavirus using hybrid capture 2 in oral brushings from patients with oropharyngeal squamous cell carcinoma. Am J Clin Pathol 2011; 135: 766-769.
38. Giovannelli L, Campisi G, Colella G, et al. Brushing of oral mucosa for diagnosis of HPV infection in patients with potentially malignant and malignant oral lesions. Mol Diagn Ther 2006; 10: 49-55.
39. Furrer VE, Benitez MB, Furnes M, Lanfranchi HE, Modesti NM,. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med 2006; 35: 338-344.
40. Watanabe S, Ogura H, Fukushima K, Yabe Y,. Comparison of Virapap filter hybridization with polymerase chain reaction and Southern blot hybridization methods for detection of human papillomavirus in tonsillar and pharyngeal cancers. Eur Arch Otorhinolaryngol 1993; 250: 115-119.
41. Warson F, Blommaert D, De Roy G,. Inflamed branchial cyst: A potential pitfall in aspiration cytology. Acta Cytol 1986; 30: 201-202.
42. Burgess KL, Hartwick RW, Bedard YC,. Metastatic squamous carcinoma presenting as a neck cyst. Differential diagnosis from inflamed branchial cleft cyst in fine needle aspirates. Acta Cytol 1993; 37: 494-498.
43. Pai RK, Erickson J, Pourmand N, Kong CS,. p16(INK4A) immunohistochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx. Cancer 2009; 117: 108-119.
44. Zhang MQ, El-Mofty SK, Dávila RM,. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: A tool for identifying the site of an occult head and neck primary. Cancer 2008; 114: 118-123.
45. Begum S, Gillison ML, Nicol TL, Westra WH,. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2007; 13: 1186-1191.
46. Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH,. Detection of human papillomavirus in cervical lymph nodes: A highly effective strategy for localizing site of tumor origin. Clin Cancer Res 2003; 9: 6469-6475.
47. Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120: 1731-1738.
48. Castro TP, Bussoloti Filho I,. Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol 2006; 72: 272-282.
49. Lingen MW,. Brush-based cytology screening in the tonsils and cervix: There is a difference! Cancer Prev Res 2011; 4: 1350-1352.
50. Fakhry C, Rosenthal BT, Clark DP, Gillison ML,. Associations between oral HPV16 infection and cytopathology: Evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res 2011; 4: 1378-1384.
51. Zhao M, Rosenbaum E, Carvalho AL, et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 2005; 117: 605-610.
52. Mehrotra R, Sharma N, Umudum H, Ceyhan K, Rezanko T,. The role of cytopathology in diagnosing HPV induced oropharyngeal lesions. Diagn Cytopathol, in press.
53. Al-Qahtani K, Brousseau V, Paczesny D, et al. Koilocytosis in oral squamous cell carcinoma: What does it mean? J Otolaryngol 2007; 36: 26-31.
54. Machado J, Reis PP, Zhang T, et al. Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol 2010; 2: 6.
55. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-1131.
56. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006; 119: 2620-2623.
57. Mehrotra R, Sharma N, Umudum H, Ceyhan K, Rezanko T,. The role of cytopathology in diagnosing HPV induced oropharyngeal lesions. Diagn Cytopathol, 2011 Jun 22 [Epub ahead of print].
58. Westra WH,. The changing face of head and neck cancer in the 21st century: The impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 2009; 3: 78-81.
59. Sedrak M, Rizzolo D,. Understanding the link between HPV and oropharyngeal cancers. JAAPA 2008; 21: 18-22.
60. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ,. Human papillomavirus and head and neck cancer: A systematic review and meta-analysis. Clin Otolaryngol 2006; 31: 259-266.
61. Campisi G, Panzarella V, Giuliani M, et al. Human papillomavirus: Its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol 2007; 30: 813-823.
62. Kreimer AR, Villa A, Nyitray AG, et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2011; 20: 172-182.
63. Kreimer AR, Bhatia RK, Messeguer AL, González P, Herrero R, Giuliano AR,. Oral human papillomavirus in healthy individuals: A systematic review of the literature. Sex Transm Dis 2010; 37: 386-391.
64. Sturgis EM, Ang KK,. The epidemic of HPV-associated oropharyngeal cancer is here: Is it time to change our treatment paradigms? J Natl Compr Canc Netw 2011; 9: 665-673.